Community Bispecific Delivery Requires Operational Readiness, Safety

As bispecific antibodies expand in myeloma and lymphoma and move into solid tumors and earlier lines of therapy, most patients will receive them in community practices. For Salman Fazal, MD, hematology lead at UPMC Hillman Cancer Center, the central question for those programs isn’t a choice between delivery and safety.

“I think it’s both,” he said.

Fazal explained that these off-the-shelf therapies are a real innovation, but access depends on execution.

“The enthusiasm is not going to operationalize or make it available for these patients,” he said.

Programs need a team that understands and champions the treatment, along with all the key players required to administer it in a community setting. That kind of preparation is what turns an approval into real access for patients treated in the community, he said.

Patient selection adds complexity. Community patients are often older, have more comorbidities, and sometimes lack a caregiver. Fazal explained that establishing a clear baseline before treatment begins is important. A patient may be on oxygen because of chronic obstructive pulmonary disease, have mild dementia, or struggle with an immune effector cell encephalopathy score assessment, such as writing a sentence. Documenting those findings lets staff know what is normal for that patient so changes during treatment can be interpreted correctly. Staff is then educated on each patient’s documented baseline.

Fazal emphasized that giving a bispecific to a patient with baseline organ or cognitive impairment remains a clinical decision. Once the baseline is known, the team determines the safest way to administer therapy for that individual. He also noted that clinical trials exclude certain patients because of comorbidities, while real-world practice treats a broader population. Clinicians have learned a great deal about delivering these agents safely to patients with baseline cognitive impairment or oxygen needs, he said, and that experience is key to giving them safely.